These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8022993)

  • 21. [Efficacy of sustained-released theophylline on peak expiratory flow rate in asthmatic patients].
    Yoshimine F; Sasagawa M; Kon Y; Yamaguchi S; Suzuki E; Gejyo F
    Arerugi; 2000 Jul; 49(7):593-9. PubMed ID: 10944826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of inhaled corticosteroid combined with theophylline and double-dose inhaled corticosteroid in moderate to severe asthma.
    Wang Y; Wang CZ; Lin KX; Qian GS; Zhuo WL; Li SP; Zhao ZQ; Liao XQ; Song YX
    Respirology; 2005 Mar; 10(2):189-95. PubMed ID: 15823184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of doxofylline compared to theophylline in chronic reversible asthma -- a double-blind randomized placebo-controlled multicentre clinical trial.
    Goldstein MF; Chervinsky P
    Med Sci Monit; 2002 Apr; 8(4):CR297-304. PubMed ID: 11951074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapeutic and toxic theophylline levels in asthma attacks--is there a need for additional theophylline?].
    Zeidman A; Gardyn J; Fradin Z; Fink G; Mittelman M
    Harefuah; 1997 Jul; 133(1-2):3-5, 80. PubMed ID: 9332046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The efficacy of theopek in bronchial asthma and chronic bronchitis].
    Korzh OB
    Ter Arkh; 1990; 62(3):82-4. PubMed ID: 2368005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical and cellular basis for circadian rhythms in obstructive lung disease and implications for theophylline therapy.
    Kunkel G; Siebert B
    Arzneimittelforschung; 1988 Aug; 38(8A):1200-2. PubMed ID: 3056428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The anti-inflammatory action of an oral sustained-release theophylline preparation. Results of a clinical pilot study with low dosages].
    Bodner A; Hens C; Moser C; Oster H
    Arzneimittelforschung; 1998 May; 48(5A):617-24. PubMed ID: 9676355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical study on the efficacy of a sustained-release theophylline-based preparation in infants with chronic asthma].
    Bertolani P; Bernini GC; Amarri S; Accorsi P
    Pediatr Med Chir; 1985; 7(5):765-9. PubMed ID: 3837245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The changing role of theophylline in pediatric asthma.
    Stoloff SW
    Am Fam Physician; 1994 Mar; 49(4):839-44. PubMed ID: 8116518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of low dose of inhaled corticosteroid combined with small dose of oral theophylline on treatment of bronchial asthma].
    Li J; Mo H; Huang H
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jun; 23(6):336-9. PubMed ID: 11778513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral fenoterol versus sustained release theophylline in adult asthmatics.
    Lucena MI; Almagro J; Andrade RJ; Hidalgo Sanchez R; Sanchez de la Cuesta F
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):19-23. PubMed ID: 9021437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The pharmacokinetics of theopek--a new Soviet prolonged-action drug form of theophylline--in patients with bronchial asthma].
    Belousov IuB; Abazova FI; Kholodov LE; Chervinskaia TA; Sokolov AV
    Farmakol Toksikol; 1989; 52(5):63-8. PubMed ID: 2599082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral doxophylline in patients with chronic obstructive pulmonary disease.
    Villani F; De Maria P; Ronchi E; Galimberti M
    Int J Clin Pharmacol Ther; 1997 Mar; 35(3):107-11. PubMed ID: 9088999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Symptoms and peak expiratory flow rate: response to a slow release theophylline preparation.
    Ho TF; Ngiam TE; Koh PK
    Singapore Med J; 1983 Oct; 24(5):280-4. PubMed ID: 6669991
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical study to evaluate the efficacy and acceptability of long-acting theophylline in children with asthma].
    Nelly RC
    Rev Alerg Mex (1987); 1988; 35(1):17-21. PubMed ID: 3369674
    [No Abstract]   [Full Text] [Related]  

  • 37. [Theopek in the treatment of patients with obstructive diseases of the respiratory organs].
    Korzh OB; Vygovskiĭ VP; Stadnicheko RA; Borzhievskaia OE; Kopel'man EI; Kozak KM; Senyk RV; Vygovskiĭ IaV
    Vrach Delo; 1990 Jan; (1):41-2. PubMed ID: 2330707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized trial of inhaled beclomethasone dipropionate versus theophylline for moderate asthma during pregnancy.
    Dombrowski MP; Schatz M; Wise R; Thom EA; Landon M; Mabie W; Newman RB; McNellis D; Hauth JC; Lindheimer M; Caritis SN; Leveno KJ; Meis P; Miodovnik M; Wapner RJ; Varner MW; O'Sullivan MJ; Conway DL; ;
    Am J Obstet Gynecol; 2004 Mar; 190(3):737-44. PubMed ID: 15042007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and pharmacodynamics of a short- and long-acting theophylline medication (Theolair and Theolair retard) in normals and asthmatics. Part II: Lung function and side effects.
    Utama I; Kreukniet J; Fokkens J; Serra R
    Int J Clin Pharmacol Ther Toxicol; 1983 Jun; 21(6):292-6. PubMed ID: 6885203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prolonged-action theophylline in the treatment of bronchial asthma].
    Ter Arkh; 1989; 61(8):30-7. PubMed ID: 2588163
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.